JULIE RUBINSTEIN, the President and COO of $ADPT, sold 6,518 shares of the company on 03-03-2026 for an estimated $106,438. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares of this class of stock. Following this trade, they now own 583,911 shares of this class of $ADPT stock.
$ADPT Insider Trading Activity
$ADPT insiders have traded $ADPT stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.
Here’s a breakdown of recent trading of $ADPT stock by insiders over the last 6 months:
- CHAD M ROBINS (CEO and Chairman) has made 0 purchases and 11 sales selling 1,024,993 shares for an estimated $16,960,221.
- SHARON BENZENO (Chief Commercial Ofc Imm Med) has made 0 purchases and 3 sales selling 619,006 shares for an estimated $10,356,402.
- FRANCIS LO (Chief People Officer) has made 0 purchases and 4 sales selling 200,999 shares for an estimated $3,311,543.
- KYLE PISKEL (Chief Financial Officer) has made 0 purchases and 4 sales selling 169,493 shares for an estimated $3,295,150.
- HARLAN S ROBINS (Chief Scientific Officer) has made 0 purchases and 8 sales selling 124,233 shares for an estimated $2,176,549.
- JULIE RUBINSTEIN (President and COO) has made 0 purchases and 4 sales selling 92,823 shares for an estimated $1,493,427.
- ROBERT HERSHBERG sold 22,968 shares for an estimated $367,488
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADPT Hedge Fund Activity
We have seen 145 institutional investors add shares of $ADPT stock to their portfolio, and 151 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP removed 6,256,847 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $93,602,431
- WESTFIELD CAPITAL MANAGEMENT CO LP added 4,060,481 shares (+inf%) to their portfolio in Q4 2025, for an estimated $65,942,211
- AMERIPRISE FINANCIAL INC removed 3,380,722 shares (-56.6%) from their portfolio in Q4 2025, for an estimated $54,902,925
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,299,635 shares (+303.4%) to their portfolio in Q4 2025, for an estimated $53,586,072
- INVESCO LTD. added 2,216,595 shares (+248.8%) to their portfolio in Q4 2025, for an estimated $35,997,502
- MACQUARIE GROUP LTD removed 2,104,414 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $34,175,683
- LORD, ABBETT & CO. LLC added 1,854,355 shares (+151.2%) to their portfolio in Q4 2025, for an estimated $30,114,725
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ADPT Revenue
$ADPT had revenues of $71.7M in Q4 2025. This is an increase of 51.04% from the same period in the prior year.
You can track ADPT financials on Quiver Quantitative's ADPT stock page.
$ADPT Analyst Ratings
Wall Street analysts have issued reports on $ADPT in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/06/2025
- BTIG issued a "Buy" rating on 11/06/2025
- Piper Sandler issued a "Overweight" rating on 10/15/2025
- Guggenheim issued a "Buy" rating on 09/30/2025
To track analyst ratings and price targets for $ADPT, check out Quiver Quantitative's $ADPT forecast page.
$ADPT Price Targets
Multiple analysts have issued price targets for $ADPT recently. We have seen 6 analysts offer price targets for $ADPT in the last 6 months, with a median target of $20.5.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $22.0 on 02/06/2026
- Sebastian Sandler from JP Morgan set a target price of $21.0 on 02/06/2026
- Subbu Nambi from Guggenheim set a target price of $21.0 on 01/26/2026
- Tejas Savant from Morgan Stanley set a target price of $16.0 on 11/11/2025
- David Westenberg from Piper Sandler set a target price of $20.0 on 10/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
